Biotech & Medtech
Biotech & Medtech news — Wednesday 07 October 2026
32 stories from 4 sources, every one in English. Each links to its publisher.
-
Trilliant Health: Misaligned Incentives Are Undermining US Healthcare
Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor health outcomes, workforce shortages and other systemic problems in U.S. healthcare. The post Trilliant Health…
-
Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform
Teladoc Health announced Wednesday that it is launching two new AI-powered capabilities built into its Solo smart care platform for hospitals and health systems to be used during virtual visits. The post Teladoc Health Adds Contactless…
-
STAT+: In small trial, optogenetics restores some vision lost to retinitis pigmentosa
Retinitis pigmentosa is a genetic disorder that causes degeneration of the light-sensing cells in the retina. Generally diagnosed in childhood or early adolescence, patients gradually lose peripheral and night vision, often becoming…
-
STAT+: Trump administration proposes $70,000 fee for popular international student work program
As part of its ongoing bid to more tightly regulate international students, the Trump administration on Wednesday announced a proposed $70,000 fee for a popular work authorization program meant to give students professional experience. The…
-
Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road
Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the business. The move follows the CRISPR biotech company’s failure to secure financing for its clinical trial plans…
-
STAT+: PhRMA sues over Trump policy mandating lower drug prices in Medicare
WASHINGTON — The brand drug industry’s main trade group is suing the Trump administration over a pilot program tying Medicare drug prices to those in peer countries. The Pharmaceutical Research and Manufacturers of America said Wednesday…
-
Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure funding to support the effort and will now pursue “strategic alternatives” instead.
-
Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial
A Dutch court barred Merck from selling subcutaneous Keytruda in several European countries. Elsewhere, an Insmed executive ended a seven-year run and two startups secured venture cash.
-
Constant Vigilance is the Watchword for Healthcare AI Governance
[Sponsored] Sponsored by Cotiviti, a webinar addressing the challenges of AI implementation and governance offered insights based on findings from the Healthcare AI Readiness Index. The post Constant Vigilance is the Watchword for…
-
STAT+: Merck suffers a setback in Europe over its new Keytruda formulation
In a setback for Merck, a Dutch court ruled that the company infringed on a patent pertaining to a subcutaneous formulation of its Keytruda cancer treatment and was ordered to halt manufacturing and marketing the medication in several…
-
STAT+: Forbion raises $2.6 billion, its largest fundraise to date
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today, STAT released our 2026 Wunderkinds, a group of early-career researchers recognized for doing…
-
PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs?
Employers are trying to comparison shop in a market where all the price tags are hidden. And most can’t simply switch PBMs to find better pricing for their members. The post PBM Transparency Is Still Too Opaque — How Can Employers Rein In…
-
STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. I have refused to read or watch “The Love Hypothesis” …
-
From Distributor to Disruptor: Amazon’s Healthcare Flex
No longer satisfied with buying pharmacies and clinics, it seems intent on owning the healthcare journey, and perhaps redrawing pharma’s commercialization map. The post From Distributor to Disruptor: Amazon’s Healthcare Flex appeared first…
-
STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While…
-
STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud
In a warning to life sciences companies, the Department of Justice last week issued a new directive for combating fraud that made a point of noting the agency will pursue violations of a federal law that tightly regulates the…
-
A Takeda spinout builds case for its Parkinson’s drug
Cerevance plans to meet with the FDA to determine next steps for a new kind of medicine known as solengepras, now that it has Phase 3 data in hand.
-
ER visits from people born outside the U.S. dropped after ICE raids
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Good morning. We’ve got a heartbreaking story from Jason Mast today on two friends with Duchenne muscular dystrophy. Read…
-
2026 Nobel Prize in chemistry awarded for ‘mirror image’ molecule research, with impact on pharmacology
Henri B. Kagan and Kenso Soai were awarded the 2026 Nobel Prize in chemistry on Wednesday for discovering how to manipulate “mirror image” molecules, paving the way for manufacturing more precise and safer drugs. Kagan, 95, of the…
-
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma, the company said Tuesday. The Berkeley, Calif.-based biotech, borne from…
-
STAT+: Democrats plot a midterms push for MAHA voters
WASHINGTON — Democrats are building bridges to a major new constituency: the Make America Healthy Again voter. As the midterms near, leaders across the party have been meeting with MAHA activists, discussing potential openings with…
-
STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few
There’s a boy like you in Minnesota, Yannick’s mom told him a few years ago. He has the same disease. He has the same kind of smile. Maybe you could talk? They clicked. After school and on weekends, the two boys boot up their computers…
-
Opinion: My oncologist recommended active surveillance for prostate cancer. Life insurers called it ‘untreated cancer’
When my term life insurance policy expired in 2013 and I had to get a new one, I thought my widow-maker heart attack in 2005 might be a sticking point. Instead, eight insurers turned me down because they said I had “untreated cancer.” They…
-
Simplified Swarm Optimization for Surrogate-Assisted Reliability Design of Insulated-Gate Bipolar Transistor Power Modules Using an Open-Source Process Finite-Element Model
arXiv:2610.07412v1 Announce Type: new Abstract: Process-induced warpage, ceramic stress and solder strain limit the reliability of insulated-gate bipolar transistor (IGBT) modules on direct-bonded copper (DBC) substrates…
-
Evolutionary One-Step Generators: Fast and Diverse Sampling for Discrete Design
arXiv:2610.08367v1 Announce Type: cross Abstract: Several discrete design tasks, such as molecular discovery, require diverse collections of useful candidates at low computational cost. High validity alone does not guarantee a useful…
-
Synapse Loss Estimation for the BrainScaleS Wafer-scale Neuromorphic System
arXiv:2610.07321v1 Announce Type: cross Abstract: Neuromorphic hardware combines memory (synapses) and computation (neurons) into the same silicon substrate to avoid the von-Neumann bottleneck. This way, neuromorphic computing aims to make…
-
On the use of evolutionary optimization for the dynamic chance constrained open-pit mine scheduling problem
arXiv:2604.13385v3 Announce Type: replace Abstract: Open-pit mine scheduling is a complex real-world optimization problem that involves uncertain economic values and dynamically changing resource capacities. Evolutionary algorithms are…
-
Common-Mode Errors Limit Low-Timestep Deep Spiking Q-Networks
arXiv:2610.07808v1 Announce Type: new Abstract: Spiking neural networks (SNNs) offer sparse and event-driven computation, making them attractive for energy-constrained reinforcement learning (RL) on edge devices. In value-based RL, deep…
-
Forecast Accuracy Is Not Trading Profit: Evolving Small Recurrent Networks for Stock Return Prediction
arXiv:2610.07825v1 Announce Type: new Abstract: Time series forecasting models are typically compared on pointwise error, which scores a prediction in isolation from the decision it is produced for, and a lower forecast error does not…
-
From Search to Signal: Online Post-Training in Automatic Heuristic Design
arXiv:2609.39383v1 Announce Type: cross Abstract: Large language model (LLM)-based automatic heuristic design (AHD) iteratively proposes and refines heuristics, pairing design rationales with executable code. Task-specific evaluators…
-
From the Drosophila Visual Connectome to General-Purpose Computer Vision
arXiv:2610.08418v1 Announce Type: cross Abstract: Biological connectomes encode structured solutions to visual computation that may provide reusable inductive biases for artificial vision. We develop ConnectomeX around FlyVision, a…
-
ReGraph: A Computational Account of Emergent Generalization in the "what" and "where" Dual Visual Streams
arXiv:2610.07962v1 Announce Type: new Abstract: Where generalization capacity--the ability to extract context-invariant relational structures--first emerges remains a central question in AI and neuroscience. The foundation for this…